How a microwave-sized device could make personalized cancer treatment more accessible
Under CEO Paul Stoffels, Belgian biotech Galapagos is testing a device that manufactures CAR-T cancer therapies in hospitals, bringing down the wait time and price. When it works, CAR-T cancer therapy can appear miraculous. With a single infusion of their own immune T-cells—genetically modified to…
#paulstoffels #belgian #galapagos #myeloma #readfullstory